search
Back to results

Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) (DYNAMMO-T2D)

Primary Purpose

Insulin Resistance

Status
Completed
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
Intralipid
Saline
Sponsored by
Pennington Biomedical Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Insulin Resistance focused on measuring Mitochondrial Dynamics, Insulin Resistance

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy
  • Sedentary
  • Normal glucose tolerance
  • BMI <25 kg/m2

Sites / Locations

  • Pennington Biomedical Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Intralipid Infusion, then Saline

Saline Infusion, then Intralipid

Arm Description

Participants in this arm will first receive a lipid infusion. Then 4 weeks later the saline infusion.

Participants in this arm will first receive a saline infusion. Then 4 weeks later the lipid infusion.

Outcomes

Primary Outcome Measures

Effects of lipid infusion on mitochondrial fission
Fission will be assessed from quantitative measures of dynamin-related protein-1. The unit of assessment is arbitrary units of blot intensity and is expressed as AU.

Secondary Outcome Measures

Effects of lipid infusion on mitochondrial function
Function will be assessed from oxygen consumption. Unit of assessment is pmol/s/mg of muscle.
Insulin sensitivity
Insulin sensitivity will be assessed by euglycemic hyperinsulinemic clamp. Units of assessment are mg/kg/min.

Full Information

First Posted
February 18, 2016
Last Updated
July 23, 2021
Sponsor
Pennington Biomedical Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02697201
Brief Title
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)
Acronym
DYNAMMO-T2D
Official Title
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO-T2D)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
July 2016 (undefined)
Primary Completion Date
May 2021 (Actual)
Study Completion Date
May 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Pennington Biomedical Research Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Insulin promotes the clearance of sugars from the blood into skeletal muscle and fat cells for use as energy; it also promotes storage of excess nutrients as fat. Type 2 diabetes occurs when the cells of the body become resistant to the effects of insulin, and this causes high blood sugar and contributes to a build-up of fat in muscle, pancreas, liver, and the heart. Understanding how insulin resistance occurs will pave the way for new therapies aimed at preventing and treating type 2 diabetes. Mitochondria are cellular structures that are responsible for turning nutrients from food, into the energy that our cells run on. As a result, mitochondria are known as "the powerhouse of the cell." Mitochondria are dynamic organelles that can move within a cell to the areas where they are needed, and can fuse together to form large, string-like, tubular networks or divide into small spherical structures. The name of this process is "mitochondrial dynamics" and the process keeps the cells healthy. However, when more food is consumed compared to the amount of energy burned, mitochondria may become overloaded and dysfunctional resulting in a leak of partially metabolized nutrients that can interfere with the ability of insulin to communicate within the cell. This may be a way for the cells to prevent further uptake of nutrients until the current supply has been exhausted. However, long term overload of the mitochondria may cause blood sugar levels to rise and lead to the development of type 2 diabetes. This study will provide information about the relationship between mitochondrial dynamics, insulin resistance and type 2 diabetes.
Detailed Description
The traditional view of mitochondria as isolated, spherical, energy producing organelles is undergoing a revolutionary transformation. Emerging data show that mitochondria form a dynamic networked reticulum that is regulated by cycles of fission and fusion. The discovery of a number of proteins that regulate these activities has led to important advances in understanding human disease. Data show that activation of dynamin related protein 1 (Drp1), a protein that controls mitochondrial fission, is reduced following exercise in prediabetes, and the decrease is linked to increased insulin sensitivity and fat oxidation. The proposed research will test the hypothesis that mitochondrial dynamics is a key mechanism of insulin resistance in type 2 diabetes. Translational first-in-man studies will use an acute lipid challenge to investigate the physiological significance of altered skeletal muscle mitochondrial dynamics on insulin sensitivity in humans. The experimental approach harnesses innovative molecular and cellular tools, interfaced with physiologically significant human studies to obtain meaningful data on insulin resistance, and has the potential to generate insights that will lead to new diabetes therapies for future generations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance
Keywords
Mitochondrial Dynamics, Insulin Resistance

7. Study Design

Primary Purpose
Basic Science
Study Phase
Early Phase 1
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intralipid Infusion, then Saline
Arm Type
Experimental
Arm Description
Participants in this arm will first receive a lipid infusion. Then 4 weeks later the saline infusion.
Arm Title
Saline Infusion, then Intralipid
Arm Type
Sham Comparator
Arm Description
Participants in this arm will first receive a saline infusion. Then 4 weeks later the lipid infusion.
Intervention Type
Drug
Intervention Name(s)
Intralipid
Other Intervention Name(s)
Liposyn
Intervention Description
0.55 ml/kg/h
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
0.55 ml/kg/h for
Primary Outcome Measure Information:
Title
Effects of lipid infusion on mitochondrial fission
Description
Fission will be assessed from quantitative measures of dynamin-related protein-1. The unit of assessment is arbitrary units of blot intensity and is expressed as AU.
Time Frame
5 years
Secondary Outcome Measure Information:
Title
Effects of lipid infusion on mitochondrial function
Description
Function will be assessed from oxygen consumption. Unit of assessment is pmol/s/mg of muscle.
Time Frame
5 years
Title
Insulin sensitivity
Description
Insulin sensitivity will be assessed by euglycemic hyperinsulinemic clamp. Units of assessment are mg/kg/min.
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Sedentary Normal glucose tolerance BMI <25 kg/m2
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John P Kirwan, Ph.D.
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pennington Biomedical Research Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34090870
Citation
Axelrod CL, Fealy CE, Erickson ML, Davuluri G, Fujioka H, Dantas WS, Huang E, Pergola K, Mey JT, King WT, Mulya A, Hsia D, Burguera B, Tandler B, Hoppel CL, Kirwan JP. Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans. Metabolism. 2021 Aug;121:154803. doi: 10.1016/j.metabol.2021.154803. Epub 2021 Jun 4.
Results Reference
derived

Learn more about this trial

Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)

We'll reach out to this number within 24 hrs